Articles

A brief overview of the plethora of findings presented at the 2021 American Academy of Ophthalmology meeting held November 12-15 in New Orleans, LA.

AAO in review: findings presented at the 2021 annual meeting

Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of 

In a poster presented at the American Academy of Ophthalmology 2021 annual meeting in New Orleans, Mark Wieland, MD, noted that the Port Delivery System with ranibizumab provides drug delivery over an extended period.

Port delivery system efficiently delivers drugs to retina in patients with wet AMD, study reports

Videos

Sunir J. Garg, MD, speaks on the influence of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-VEGF injections.

Universal face masking during anti-VEGF injections reduces endophthalmitis incidence

During a presentation at the American Academy of Ophthalmology 2021 annual meeting in New Orleans, Veeral Sheth, MD, presented research that found faricimab, a bispecific monoclonal antibody, provided sustained retinal stability in patients with diabetic macular edema (DME) compared with other retinal treatments.

Sustained retinal stability achieved in DME with faricimab, study finds

Speaking at the American Academy of Ophthalmology 2021 annual meeting in New Orleans, Ines Lains, MD, PhD, explained that the mechanisms of AMD progression currently remain poorly understood and the tools to predict and halt progression are limited.

Plasma metabolomic profiles linked with AMD progression

VUITY, the first and only approved eye drop to treat age-related blurry near vision, provides opportunities for patients looking for spectacle independence.

Presbyopia-correcting drops and their potential for frustrated patients

Ajay Kuriyan, MD, discusses his poster at AAO, "Fluctuations in central subfield thickness associated with worse visual outcomes in patients with diabetic macular edema in clinical trial setting."

DME: Changes to central subfield thickness linked to worse visual outcomes

Verana Health showcases the VeraQ quality measures dashboard  for the IRIS registry report at AAO 2021.

New quality measures dashboard from Verana Health unveiled at AAO

Mohamed Abou Shousha, MD, PhD, discusses Heru’s wearable AI-powered diagnostic devices at AAO 2021.

Wearable diagnostic platform addresses gaps in vision care

Bausch + Lomb's Yolande Barnard shares an update on the FDA approval of XIPERE for the treatment of macular edema associated with uveitis. 

New quality measures dashboard from Verana Health unveiled at AAO

Wearable diagnostic platform addresses gaps in vision care

Update on FDA approval of XIPERE for macular edema associated with uveitis from Bausch + Lomb